astatine and Carcinoma--Non-Small-Cell-Lung

astatine has been researched along with Carcinoma--Non-Small-Cell-Lung* in 1 studies

Other Studies

1 other study(ies) available for astatine and Carcinoma--Non-Small-Cell-Lung

Article	Year
Evaluation of astatine-211-labeled octreotide as a potential radiotherapeutic agent for NSCLC treatment. Bioorganic & medicinal chemistry, 2018, 03-01, Volume: 26, Issue:5 Octreotide is a somatostatin (SST) analogue currently used in the treatment of neuroendocrine tumors (NETs) with high binding affinity for the somatostatin receptor-2 (SSTR2) that is also overexpressed in non-small cell lung cancer cell (NSCLC). Alpha-particle-emitting astatine-211 ( Topics: Animals; Antineoplastic Agents; Astatine; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Humans; Lung Neoplasms; Mice; Mice, Nude; Octreotide; Radiopharmaceuticals; Tissue Distribution; Transplantation, Heterologous	2018

Article

Year

Evaluation of astatine-211-labeled octreotide as a potential radiotherapeutic agent for NSCLC treatment.

Bioorganic & medicinal chemistry, 2018, 03-01, Volume: 26, Issue:5

Octreotide is a somatostatin (SST) analogue currently used in the treatment of neuroendocrine tumors (NETs) with high binding affinity for the somatostatin receptor-2 (SSTR2) that is also overexpressed in non-small cell lung cancer cell (NSCLC). Alpha-particle-emitting astatine-211 (

Topics: Animals; Antineoplastic Agents; Astatine; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Humans; Lung Neoplasms; Mice; Mice, Nude; Octreotide; Radiopharmaceuticals; Tissue Distribution; Transplantation, Heterologous

2018